Smartleaf Asset Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Smartleaf Asset Management LLC
- $1.04 Trillion
- Q1 2025
A detailed history of Smartleaf Asset Management LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 279 shares of KALV stock, worth $3,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
279
Previous 306
8.82%
Holding current value
$3,292
Previous $2.57 Million
29.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KALV
# of Institutions
139Shares Held
54.4MCall Options Held
1.38MPut Options Held
6K-
Vr Adviser, LLC New York, NY6.7MShares$79.1 Million18.68% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$58.3 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$58 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$57.7 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$56.1 Million3.92% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $290M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...